RESEARCHER PROFILE

Javier Brahm

← Back to Universidad de Los Andes, Chile

J

Universidad de Los Andes, Chile

Hepatitis C virus researchHepatitis B Virus StudiesLiver Disease and TransplantationDrug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and Treatment

Javier Brahm works in Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation, Drug-Induced Hepatotoxicity and Protection, Liver Disease Diagnosis and Treatment. Recorded institutional associations include Universidad de Los Andes, Chile.

128Publications
1,864Citations
18H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Prospective Study of Bacterial Infection in Acute Liver Failure: An Analysis of Fifty Patients

    1990 · 323 citations
  2. LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION

    1987 · 256 citations
  3. Fungal infection: a common, unrecognised complication of acute liver failure

    1991 · 196 citations
  4. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids

    2014 · 119 citations
  5. Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation

    1990 · 81 citations
  6. Platelet autoantibodies in patients with chronic liver disease

    1995 · 72 citations
  7. Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group

    2025 · 60 citations
  8. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone

    1997 · 56 citations
  9. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver

    2021 · 54 citations
  10. Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

    2021 · 41 citations
  11. When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)

    2019 · 38 citations
  12. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports

    2014 · 36 citations
  13. Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients.

    1997 · 33 citations
  14. [Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population].

    1998 · 25 citations
  15. Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection

    2011 · 22 citations
  16. Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network

    2024 · 22 citations
  17. Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile

    2008 · 19 citations
  18. Small bowel motility in primary biliary cirrhosis

    1998 · 18 citations
  19. Full-Genome Sequence of a Hepatitis B Virus Genotype F1b Clone from a Chronically Infected Chilean Patient

    2014 · 18 citations
  20. Outcomes of orthotopic liver transplantation in Chile

    2003 · 17 citations
  21. Movement disorders as a manifestation of metronidazole‐induced encephalopathy in a patient with chronic liver disease

    2009 · 14 citations
  22. [Hepatitis E virus infection in Chile: preliminary report].

    1996 · 14 citations
  23. IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study

    2016 · 14 citations
  24. Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients

    2022 · 14 citations
  25. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection

    1986 · 12 citations

← Return to the university profile